REQUEST A DEMO
Total
USD $0.00
Search more companies

Central Pharmacy Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Central Pharmacy Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Central Pharmacy Sdn. Bhd. is based in Malaysia. The head office is in Sibu. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on May 22, 1979. From the latest financial highlights, Central Pharmacy Sdn. Bhd. reported a net sales revenue increase of 30.53% in 2022. Its’ total assets recorded a growth of 36.67%. Central Pharmacy Sdn. Bhd.’s net profit margin increased by 1.03% in 2022.

Headquarters
18 Lorong Bukit Lima Timur 2A,
Sibu; Sarawak; Postal Code: 96000

Contact Details: Purchase the Central Pharmacy Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Central Pharmacy Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Central Pharmacy Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Central Pharmacy Sdn. Bhd. report to view the information.
Incorporation Date:
May 22, 1979
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Subsidiaries
Pharmserve Pharma Sdn. Bhd.
20%
Company Performance
Financial values in the chart are available after Central Pharmacy Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
30.53%
Total operating revenue
30.53%
Operating profit (EBIT)
62.05%
EBITDA
55.46%
Net Profit (Loss) for the Period
64.21%
Total assets
36.67%
Total equity
32.11%
Operating Profit Margin (ROS)
1.19%
Net Profit Margin
1.03%
Return on Equity (ROE)
4.75%
Debt to Equity Ratio
-14.46%
Quick Ratio
-0.19%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?